The form is not published.

Heading

Living with FL: Coping with the Down Days

Living with FL: Coping with the Down Days

Join us for a free informative webinar on 'Coping with the Down Days' discussed by FLF CMO, a GP with ...
/
Brandon's Story

Brandon’s Story

I found a lump on my right thigh and was worried it would be a hernia. I went to the ...
/
2025 Impact Round-Up: Turning Belief into Progress for Follicular Lymphoma

2025 Impact Round-Up: Turning Belief into Progress for Follicular Lymphoma

In 2025 the FLF accelerated scientific momentum, strengthened global collaboration, and elevated the patient voice. In her first year as ...
/
Updates from the 2025 American Society of Hematology (ASH) Annual Meeting

Updates from the 2025 American Society of Hematology (ASH) Annual Meeting

The Follicular Lymphoma Foundation at the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, one of the world’s ...
/
Vikki's Story

Vikki’s Story

I remember everything about the day I was diagnosed with FL. And I remember my husband crying for the first ...
/
Epcoritamab-bysp in Combination with Rituximab and Lenalidomide Approved as Treatment Option for Relapsed or Refractory Follicular Lymphoma in the U.S.

Epcoritamab-bysp in Combination with Rituximab and Lenalidomide Approved as Treatment Option for Relapsed or Refractory Follicular Lymphoma in the U.S.

On November 18, 2025, the FDA approved epcoritamab-bysp (EPKINLY®) in combination with rituximab and lenalidomide for adults with relapsed or ...
/